SCHEMBL7223232

SCHEMBL7223232

CC(C)(C)Nc1ccccc1C(N)=O

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.54
ALDH1A1 P00352 3/20 0.54
SIRT2 Q8IXJ6 5/20 0.50
CLCN2 P51788 1/20 0.49
TNIK Q9UKE5 1/20 0.48
HPGD P15428 2/20 0.47
PDCD1 Q15116 1/20 0.46
CD274 Q9NZQ7 1/20 0.46
POLB P06746 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MEN1 O00255 2/20 0.45
MAPT P10636 2/20 0.45
KMT2A Q03164 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
PKM P14618 1/20 0.45
TSHR P16473 1/20 0.45
HSD17B10 Q99714 1/20 0.45
SIRT1 Q96EB6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13788818 0.82 PDK1 (0.54) KDM4EPOLB
SCHEMBL1906473 0.82 CLCN2 (0.53) KDM4EALDH1A1CLCN2HPGDMEN1
SCHEMBL173853 0.81 SIRT2 (0.49) KDM4EALDH1A1SIRT2CLCN2HPGD
SCHEMBL8818967 0.78 KMT2A (0.58) ALDH1A1MEN1MAPTKMT2A
SCHEMBL769767 0.78 ELANE (0.51) KDM4EALDH1A1CLCN2HPGDSMN1; SMN2
SCHEMBL3078843 0.78 KDM4E (0.72) KDM4EALDH1A1SIRT2TNIKHPGD
SCHEMBL704708 0.78 KDM4E (0.62) KDM4EALDH1A1SIRT2CLCN2HPGD
SCHEMBL10424663 0.77 SIRT2 (0.62) KDM4EALDH1A1SIRT2CLCN2HPGD
SCHEMBL9921482 0.77 KDM4E (0.56) KDM4EALDH1A1SIRT2HPGDPDCD1
SCHEMBL175535 0.77 KDM4E (0.56) KDM4EALDH1A1SIRT2HPGDPDCD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115819338-B Preparation method of o-tertiary butyl amino benzamide derivative 常州大学 2025-04-25 CN claimed
CN-115819338-A Preparation method of o-tert-butylamino benzamide derivative 常州大学 2023-03-21 CN claimed
CN-115819338-B Preparation method of o-tertiary butyl amino benzamide derivative 常州大学 2025-04-25 CN disclosed
CN-115819338-B Preparation method of o-tertiary butyl amino benzamide derivative 常州大学 2025-04-25 CN disclosed
CN-115819338-A Preparation method of o-tert-butylamino benzamide derivative 常州大学 2023-03-21 CN disclosed
CN-115819338-A Preparation method of o-tert-butylamino benzamide derivative 常州大学 2023-03-21 CN disclosed
CN-115819338-A Preparation method of o-tert-butylamino benzamide derivative 常州大学 2023-03-21 CN disclosed
US-8236953-B2 Process for preparing piper azine derivatives GLAXO GROUP LIMITED (GB) 2012-08-07 US disclosed
US-20110275815-A1 BENZYLPIPERAZINE DERIVATIVES AS MOTILIN RECEPTOR ANTAGONISTS SEAL JONATHAN THOMAS 2011-11-10 US disclosed
US-6521603-B2 Amide, thioamide, amidine and thioester derivatives containing a benzene, pyridine, thiophene, furan, pyrrole, pyrazole, thiazole or isothiazole ring MONSANTO TECHNOLOGY LLC 2003-02-18 US disclosed
US-6410558-B1 USING INDOLE OR QUINOLINE COMPOUND MONSANTO TECHNOLOGY LLC 2002-06-25 US disclosed
US-5998466-A PREPLANTING MONSANTO COMPANY (US) 1999-12-07 US disclosed
US-5849723-A Fungicides for the control of take-all disease of plants MONSANTO COMPANY (US) 1998-12-15 US disclosed
US-5834447-A THIOPHENE DERIVATIVES MONSANTO COMPANY (US) 1998-11-10 US disclosed
US-5811411-A Fungicides for the control of take-all disease of plants MONSANTO COMPANY (US) 1998-09-22 US disclosed
US-5705513-A HETEROCYCLIC FUNGICIDES WITH PYRIDINE OR FURAN RINGS MONSANTO COMPANY (US) 1998-01-06 US disclosed
US-5693667-A Fungicides for the control of take-all disease of plants MONSANTO COMPANY (US) 1997-12-02 US disclosed
US-5498630-A SUBSTITUTED BENZOTHIOPHENECARBOXAMIDES MONSANTO COMPANY (US) 1996-03-12 US disclosed
WO-1993007751-A1 FUNGICIDES FOR THE CONTROL OF TAKE-ALL DISEASE OF PLANTS MONSANTO COMPANY (US) 1993-04-29 WO disclosed
EP-0538231-A1 Fungicides for the control of take-all disease of plants MONSANTO COMPANY (US) 1993-04-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275815-A1 BENZYLPIPERAZINE DERIVATIVES AS MOTILIN RECEPTOR ANTAGONISTS GPR68, GPR52, GPR88 KDM4E 4252/4885ALDH1A1 3575/4885SIRT2 2956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.